Cellyan Biotechnology Co., Ltd (HKPD)

NASDAQ: HKPD · Real-Time Price · USD

0.4087

-0.0003 (-0.07%)

At close: Aug 21, 2026, 4:00 PM EDT

0.4099

+0.0012 (0.29%)

After-hours: Aug 21, 2026, 4:00 PM EDT

Cellyan Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Cash & Equivalents	0.22	0.75	0.62	0.52
Trading Asset Securities	-	2.26	-	-
Cash & Short-Term Investments	0.22	3.01	0.62	0.52
Cash Growth	-92.62%	385.10%	18.10%	-
Accounts Receivable	3.8	4.66	3.7	1.7
Other Receivables	1.39	0.06	0.02	0.03
Receivables	5.19	4.71	3.72	1.73
Inventory	0.36	0.56	0.93	0.19
Prepaid Expenses	6.32	0.16	0.09	0.07
Restricted Cash	-	0	0.01	-
Other Current Assets	0.24	0.28	2.44	0.24
Total Current Assets	12.33	8.73	7.8	2.75
Property, Plant & Equipment	0.43	0.59	0.83	0.65
Other Intangible Assets	0.08	0.1	0.03	0
Total Assets	12.84	9.42	8.67	3.41

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Accounts Payable	1.54	1.82	1.82	1.68
Accrued Expenses	-	-	0.09	0.15
Short-Term Debt	-	-	0.03	-
Current Portion of Long-Term Debt	0.88	0.37	0.18	0.06
Current Portion of Leases	0.31	0.49	0.63	0.36
Current Income Taxes Payable	0.02	0.11	0.22	0.02
Current Unearned Revenue	0.13	0.12	0.19	0.27
Other Current Liabilities	0.32	0	0	0.01
Total Current Liabilities	3.2	2.92	3.18	2.55
Long-Term Debt	-	1.5	1.12	0.12
Long-Term Leases	0.07	0.01	0.12	0.15
Total Liabilities	3.26	4.43	4.41	2.82

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Common Stock	0.02	0.01	0.01	0.01
Additional Paid-In Capital	8.95	3.46	3.02	0.39
Retained Earnings	0.37	1.5	1.53	0.2
Comprehensive Income & Other	0.24	0.01	-0.3	-0.01
Shareholders' Equity	9.58	4.99	4.25	0.59
Total Liabilities & Equity	12.84	9.42	8.67	3.41

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Total Debt	1.26	2.37	2.09	0.69
Net Cash (Debt)	-1.04	0.63	-1.47	-0.17
Net Cash Growth	-	-	-	-
Net Cash Per Share	-0.04	0.06	-0.20	-0.02
Filing Date Shares Outstanding	23.5	11	10	6.84
Total Common Shares Outstanding	23.5	11	10	6.84
Working Capital	9.14	5.81	4.63	0.2
Book Value Per Share	0.41	0.45	0.43	0.09
Tangible Book Value	9.51	4.89	4.22	0.58
Tangible Book Value Per Share	0.40	0.44	0.42	0.08
Machinery	0.17	0.19	0.14	0.18
Leasehold Improvements	0.06	0.07	0.05	0.02

SEC Filings: 10-K · 10-Q